−49.44 MUSD
15.33 MUSD
242.80 M
About PureTech Health PLC
Sector
Industry
CEO
Bharatt M. Chowrira
Website
Headquarters
Boston
Founded
2015
ISIN
GB00BY2Z0H74
FIGI
BBG009PZZ747
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PTCHF is 2.78 USD — it has increased by 4.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PureTech Health PLC stocks are traded under the ticker PTCHF.
PureTech Health PLC is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PTCHF stock is 4.44% volatile and has beta coefficient of 1.95. Check out the list of the most volatile stocks — is PureTech Health PLC there?
One year price forecast for PureTech Health PLC has a max estimate of 7.81 USD and a min estimate of 5.80 USD.
PTCHF earnings for the last quarter are −0.08 USD per share, whereas the estimation was 0.03 USD resulting in a −329.41% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about PureTech Health PLC earnings.
PureTech Health PLC revenue for the last quarter amounts to 8.60 M USD despite the estimated figure of 7.80 M USD. In the next quarter revenue is expected to reach 109.20 M USD.
Yes, you can track PureTech Health PLC financials in yearly and quarterly reports right on TradingView.
PTCHF stock has fallen by 1.42% compared to the previous week, the month change is a 9.02% rise, over the last year PureTech Health PLC has showed a 2.96% increase.
Today PureTech Health PLC has the market capitalization of 697.38 M, it has decreased by 1.26% over the last week.
No, PTCHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTCHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PureTech Health PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PureTech Health PLC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PureTech Health PLC stock shows the buy signal. See more of PureTech Health PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PureTech Health PLC future price: according to them, PTCHF price has a max estimate of 7.81 USD and a min estimate of 5.80 USD. Read a more detailed PureTech Health PLC forecast: see what analysts think of PureTech Health PLC and suggest that you do with its stocks.